Allogene Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $88.8M | $717.8M | $175.1M |
| FY2020 | $148.2M | $1.23B | $183.4M |
| FY2021 | $125.6M | $1.05B | $173.3M |
| FY2022 | $112.8M | $978.1M | $84.5M |
| FY2023 | $158.1M | $750.1M | $109.9M |